Annals of Vascular Surgery
Volume 21, Issue 6 , Pages 695-703 , November 2007

The Natural History of Stenoses within Lower Limb Arterial Bypass Grafts Using a Graft Surveillance Program

References 

  1. Baldwin ZK, Pearce BJ, Curi MA, et al. Limb salvage after infra-inguinal bypass graft failure. J Vasc Surg. 2004;39:951–957
  2. Adam DJ, Gillies TE, Kelman J, Allan PL, Chalmers RT. Vascular Surgical Society of Great Britain and Ireland. Duplex surveillance does not enhance infra-inguinal prosthetic bypass graft patency. Br J Surg. 1999;86:705
  3. Adam DJ, Stonebridge PA, Belch JJ, Murie JA. Antiplatelet and anticoagulant therapy to prevent bypass graft thrombosis in patients with lower extremity arterial occlusive disease. Int Angiol. 2001;20:90–98
  4. Haruguchi H, Teraoka S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review. J Artif Organs. 2003;6:227–235
  5. Sarkar S, Salacinski HJ, Hamilton G, Seifalian AM. The mechanical properties of infra-inguinal vascular bypass grafts: their role in influencing patency. Eur J Vasc Endovasc Surg. 2006;31(6):627–636
  6. Willis AI, Pierre-Paul D, Sumpio BE, Gahtan V. Vascular smooth muscle cell migration: current research and clinical implications. Vasc Endovascular Surg. 2004;38:11–23
  7. Tai NR, Salacinski HJ, Edwards A, Hamilton G, Seifalian AM. Compliance properties of conduits used in vascular reconstruction. Br J Surg. 2000;87:1516–1524
  8. Davies AH, Hawdon AJ, Sydes MR, Thompson SG. Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation. 2005;112:1985–1991
  9. Henke PK, Proctor MC, Zajkowski PJ, et al. Tissue loss, early primary graft occlusion, female gender, and a prohibitive failure rate of secondary infra-inguinal arterial reconstruction. J Vasc Surg. 2002;35:902–909
  10. Nackman GB, Walsh DB, Fillinger MF, et al. Thrombolysis of occluded infra-inguinal vein grafts: predictors of outcome. J Vasc Surg. 1997;25:1023–1032
  11. Seabrook GR, Mewissen MW, Schmitt DD, et al. Percutaneous intraarterial thrombolysis in the treatment of thrombosis of lower extremity arterial reconstructions. J Vasc Surg. 1991;13:646–651
  12. Rhodes JM, Gloviczki P, Bower TC, Panneton JM, Canton LG, Toomey BJ. The benefits of secondary interventions in patients with failing or failed pedal bypass grafts. Am J Surg. 1999;178:151–155
  13. Bergamini TM, George SM, Massey HT, et al. Intensive surveillance of femoropopliteal-tibial autogenous vein bypasses improves long-term graft patency and limb salvage. Ann Surg. 1995;221:507–516
  14. Belkin M, Schwartz LB, Donaldson MC, Mannick JA, Whittemore AD. Hemodynamic impact of vein graft stenoses and their prediction in the vascular laboratory. J Vasc Surg. 1997;25:1016–1022
  15. Idu MM, Buth J, Hop WC, Cuypers P, van de Pavoordt ED, Tordoir JM. Vein graft surveillance: is graft revision without angiography justified and what criteria should be used?. J Vasc Surg. 1998;27:399–413
  16. Moneta GL, Yeager RA, Antonovic R, et al. Accuracy of lower extremity arterial duplex mapping. J Vasc Surg. 1992;15:275–284
  17. Papanicolaou G, Zierler RE, Beach KW, Isaacson JA, Strandness DE. Hemodynamic parameters of failing infra-inguinal bypass grafts. Am J Surg. 1995;169:238–244
  18. Barnes RW, Thompson BW, MacDonald CM, et al. Serial noninvasive studies do not herald postoperative failure of femoropopliteal or femorotibial bypass grafts. Ann Surg. 1989;210:486–494
  19. Davies AH, Magee TR, Tennant SG, Lamont PM, Baird RN, Horrocks M. Criteria for identification of the “at-risk” infra-inguinal bypass graft. Eur J Vasc Surg. 1994;8:315–319
  20. McLafferty RB, Moneta GL, Taylor LM, Porter JM. Ability of ankle-brachial index to detect lower-extremity atherosclerotic disease progression. Arch Surg. 1997;132:836–841
  21. Papanicolaou G, Beach KW, Zierler RE, Strandness DE. The relationship between arm-ankle pressure difference and peak systolic velocity in patients with stenotic lower extremity vein grafts. Ann Vasc Surg. 1995;9:554–560
  22. Golledge J, Beattie DK, Greenhalgh RM, Davies AH. Have the results of infra-inguinal bypass improved with the widespread utilisation of postoperative surveillance?. Eur J Vasc Endovasc Surg. 1996;11:388–392
  23. Idu MM, Blankenstein JD, de Gier P, Truyen E, Buth J. Impact of a color-flow duplex surveillance program on infra-inguinal vein graft patency: a five-year experience. J Vasc Surg. 1993;17:42–53
  24. Lundell A, Lindblad B, Bergqvist D, Hansen F. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg. 1995;21:26–34
  25. Mattos MA, van Bemmelen PS, Hodgson KJ, Ramsey DE, Barkmeier LD, Sumner DS. Does correction of stenoses identified with color duplex scanning improve infra-inguinal graft patency?. J Vasc Surg. 1993;17:54–66
  26. Ihlberg L, Luther M, Tierala E, Lepantalo M. The utility of duplex scanning in infra-inguinal vein graft surveillance: results from a randomised controlled study. Eur J Vasc Endovasc Surg. 1998;16:19–27
  27. Calligaro KD, Doerr K, McAffee-Bennett S, Krug R, Raviola CA, Dougherty MJ. Should duplex ultrasonography be performed for surveillance of femoropopliteal and femorotibial arterial prosthetic bypasses?. Ann Vasc Surg. 2001;15:520–524
  28. Dormandy JA, Rutherford RB Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg. 2000;31(1 pt 2):S1–S296
  29. Buth J, Disselhoff B, Sommeling C, Stam L. Color-flow duplex criteria for grading stenosis in infra-inguinal vein grafts. J Vasc Surg. 1991;14:716–728
  30. Westerband A, Mills JL, Kistler S, Berman SS, Hunter GC, Marek JM. Prospective validation of threshold criteria for intervention in infra-inguinal vein grafts undergoing duplex surveillance. Ann Vasc Surg. 1997;11:44–48
  31. Gibson KD, Caps MT, Gillen D, Bergelin RO, Primozich J, Strandness DE. Identification of factors predictive of lower extremity vein graft thrombosis. J Vasc Surg. 2001;33:24–31
  32. Willigendael EM, Teijink JA, Bartelink ML, Peters RJ, Buller HR, Prins MH. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg. 2005;42:67–74
  33. Bandyk DF. Essentials of graft surveillance. Semin Vasc Surg. 1993;6:92–102
  34. Gentile AT, Mills JL, Gooden MA, et al. Identification of predictors for lower extremity vein graft stenosis. Am J Surg. 1997;174:218–221
  35. Mills JL, Wixon CL, James DC, Devine J, Westerband A, Hughes JD. The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair. J Vasc Surg. 2001;33:273–280
  36. Caps MT, Cantwell-Gab K, Bergelin RO, Strandness DE. Vein graft lesions: time of onset and rate of progression. J Vasc Surg. 1995;22:466–475
  37. Fujitani RM. Revision of the failing vein graft: outcome of secondary operations. Semin Vasc Surg. 1993;6:118–129
  38. Martinez ME, Reid M, Jiang R, Einspahr J, Alberts DS. Accuracy of self-reported smoking status among participants in a chemoprevention trial. Prev Med. 2004;38:492–497
  39. Webb DA, Boyd NR, Messina D, Windsor RA. The discrepancy between self-reported smoking status and urine continine levels among women enrolled in prenatal care at four publicly funded clinical sites. J Public Health Manag Pract. 2003;9:322–325
  40. Weissfeld JL, Holloway JJ, Kirscht JP. Effects of deceptive self-reports of quitting on the results of treatment trials for smoking: a quantitative assessment. J Clin Epidemiol. 1989;42:231–243
  41. Abbruzzese TA, Havens J, Belkin M, et al. Statin therapy is associated with improved patency of autogenous infra-inguinal bypass grafts. J Vasc Surg. 2004;39:1178–1185
  42. Henke PK, Blackburn S, Proctor MC, et al. Patients undergoing infra-inguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg. 2004;39:357–365
  43. Porter KE, Naik J, Turner NA, Dickinson T, Thompson MM, London NJ. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg. 2002;36:150–157

PII: S0890-5096(07)00284-1

doi: 10.1016/j.avsg.2007.07.019

Annals of Vascular Surgery
Volume 21, Issue 6 , Pages 695-703 , November 2007

Article Tools

* Image Usage & Resolution